Skip to the rundown
GetYourBrief
Search

Company · in the news since February 19, 2026

Vertex Pharmaceuticals news

Vertex Pharmaceuticals appeared in 9 news events on GetYourBrief between February 19, 2026 and September 3, 2026, on the Biotech, Healthcare and SaaS desks and 1 more. The latest: "FDA approves Casgevy gene therapy for children with sickle cell disease" (July 8, 2026).

When was Vertex Pharmaceuticals in the news?

News events naming Vertex Pharmaceuticals per month (one per story, however many outlets carried it). Source: GetYourBrief's record of the outlets' reports. April 2026 and May 2026: the intake of reports was interrupted, so these months undercount.

The latest news about Vertex Pharmaceuticals

  1. Jul 8 · Biotech FDA approves Casgevy gene therapy for children with sickle cell disease 1
  2. Jul 7 · AI AI stocks sink and drag markets lower worldwide 8
  3. Mar 14 · SaaS Seeking Alpha: “Highest and lowest quant-rated technology stocks above $10B cap after earnings season” 1
  4. Mar 11 · Biotech Seeking Alpha: “Cathie Wood buys the dip in gene-editing firm CRISPR Therapeutics” 1
  5. Mar 10 · Healthcare Vertex says kidney drug met goal in late-stage trial 1
  6. Feb 18 · Healthcare finanznachrichten.de: “Grünenthal Group: Grünenthal proprietary NaV 1.8 inhibitor enters clinical development” 2

Which desks cover Vertex Pharmaceuticals?

  1. Biotech 5
  2. Healthcare 2
  3. SaaS 1
  4. AI 1

Which outlets cover Vertex Pharmaceuticals most?

  1. Seeking Alpha 2
  2. fool.com 2

Counted over the latest 9 events; one per outlet per event. Source: the reports linked on each event.

Who appears in the news with Vertex Pharmaceuticals?

  1. Food and Drug Administration 4
  2. CRISPR Therapeutics 3
  3. Crinetics Pharmaceuticals 2
  4. Casgevy 2

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).